孟凡强CRO的潜力（Meng Fanqiang the potential of CRO）.docVIP

孟凡强CRO的潜力（Meng Fanqiang the potential of CRO） For the entire pharmaceutical industry, regardless of the media rendering or policy support, now we can then see and feel the explosive Chinese is the reform of the growth of the OTC Market -- data show that in 2011, Chinas pharmaceutical market will reach $50 billion, with sales of over ten billion yuan to dozens of pharmaceutical enterprises; and we cant see it so far, there is no Chinese officially registered in the FDA drug product production line; most of the domestic pharmaceutical companies because of the lack of core technology, still rely on go to earn a meager profit. The shadow behind these sunshine is the situation that Meng Fanqiang has been worried about and expected to change in the Chinese medicine industry for more than ten years. How can we change the overall backwardness of Chinas innovative pharmaceutical industry? In Meng Fanqiangs view, CRO is most likely to become a breakthrough. Because the research and development of new drugs is a costly, long cycle, high risk cause. The cycle of new drug research and development is usually 8~14 years and costs $8~10. But since the patent period of the new medicine is limited, if it can shorten the development cycle and let the product enter the market earlier, it is possible to recover its R D investment faster and gain more profits. The key to solve this problem lies in how to obtain high quality research and low cost investment in the whole new drug development process. Therefore, many pharmaceutical companies in the pharmaceutical R D outsourcing transfer to low-cost market (Contract Research Organization, referred to as CRO), is currently the worlds CRO business, the annual growth rate remained at more than 30%. These services, including new product development, preclinical trials and clinical trials, data management, new drug applications and other technical services, almost cover the whole process of new drug research and development. It is the most app